Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

ARI Launches New Assay Prep System for Drug Discovery

Published: Tuesday, November 06, 2012
Last Updated: Tuesday, November 06, 2012
Bookmark and Share
Non-contact dispenser sets a new benchmark for flexible, low-volume assay assembly.

Art Robbins Instruments (ARI) has announced the launch of their Cobra 148 non-contact dispensers. These affordably-priced liquid handling systems were designed for use in a wide range of drug discovery applications and enable low-volume, non-contact reagent dispensing for assay assembly and plate preparation.

Rapid, reliable assembly of assay reagents is critical for biochemical and cell-based assay development, especially when low-volume assays are required.

The Cobra 148 systems finally provide assay developers with the freedom and flexibility to design assays using precious or costly reagents and cells without constraint, dispensing them at low volumes in a microplate format.

Scientists have complete control over the volume dispensed, and can set individual well dispense volumes to as low as 300 nanoliters, enabling complex concentration gradients and even sparse-matrix assay development strategies.

Researchers in drug discovery and other areas that require a large number of data points per assay are now also able to dispense a broad range of volumes of up to four reagents into 96-, 384- and 1536-well microplates.

With an option for on-the-fly dispensing, 300 nanoliters can be dispensed into an entire 384 well microplate in 14 seconds. Twenty-five microliters require only 39 seconds.

Aspiration and dispensing from microplates is a standard feature in the 1 and 4 channel models, virtually eliminating dead volumes and preserving precious reagents.

A dedicated 8-channel bulk dispensing system is available for very high throughput applications.

“Assembling microplate-based assays is a fundamental part of drug discovery and life science research, the instrumentation has to be fast, robust and fit seamlessly into user’s workflows” commented Art Robbins, founder of ARI.

Robbins continued, “We’ve applied our years of experience in developing non-contact dispensers for protein crystallography applications to the Cobra 148 systems so that researchers can take advantage of the same speed and reliability for their assay development and screening applications.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Preventing Breast Cancer with Hops
Study of hops extract suggests prevention of breast cancer through chemical pathway activation.
Treatment Advancement for Gaucher and Parkinson's Diseases
NIH scientists identify molecule that may act as a possible treatment of neurological diseases.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
New Treatment for Rare Blood Cancers
Drug called midostaurin showed promise in an international clinical trial led by a Stanford physician.
Biomarker for Parkinson's Disease Found in Urine Samples
Protein identified as Parkinson's biomarker sourced from patient's stored frozen urine samples.
Testing for Malaria or Cancer at Home
Chemist develops tech to save lives in rural Africa.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!